Examples of such efforts include the discovery of novel cerebrospinal fluid proteins that are differentially expressed during the course of AD progression [26], the development of novel positron emission tomography ligands used to study neuropathologic correlates of disease progression [27], as well as the use of noninvasive home motor activity monitoring [28].